XML 58 R44.htm IDEA: XBRL DOCUMENT v3.24.2.u1
EQUITY, LONG-TERM INCENTIVE COMPENSATION PLANS AND NON-CONTROLLING INTEREST (Tables)
 12 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Combined Activity Under Equity Incentive Plans
The following table summarizes the combined activity under our equity incentive plans:
(In thousands)
Available
For Grant(1)(4)
Balances as of June 30, 202110,253 
RSUs granted(2)
(1,152)
RSUs granted adjustment(3)
39 
RSUs canceled102 
Balances as of June 30, 20229,242 
RSUs granted(2)
(1,601)
RSUs canceled120 
Balances as of June 30, 20237,761 
Plan shares increased3,250 
RSUs granted(2)
(849)
RSUs canceled78 
Balances as of June 30, 202410,240 
__________________
(1)The number of RSUs reflects the application of the award multiplier of 2.0x as described above.
(2)Includes RSUs granted to senior management with performance-based vesting criteria (in addition to service-based vesting criteria for any of such RSUs that are deemed to have been earned) (“performance-based RSU”). As of June 30, 2024, it had not yet been determined the extent to which (if at all) the performance-based vesting criteria had been satisfied. Therefore, this line item includes all such performance-based RSUs granted during the fiscal year, reported at the maximum possible number of shares that may ultimately be issuable if all applicable performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied (0.2 million shares, 0.6 million shares and 0.2 million shares for the fiscal years ended June 30, 2024, 2023 and 2022, respectively, reflecting the application of the 2.0x multiplier described above).
(3)Represents the portion of RSUs granted with performance-based vesting criteria and reported at the actual number of shares issued upon achievement of the performance vesting criteria during the fiscal years ended June 30, 2024, 2023, and 2022.
(4)No additional stock options, RSUs or other awards will be granted under the Assumed Equity Plans.
Schedule of Stock-based Compensation Expense
The following table shows SBC expense for the indicated periods:
Year Ended June 30,
(In thousands)202420232022
SBC expense by:
Costs of revenues$35,942 $29,101 $21,108 
R&D60,124 44,702 27,618 
SG&A116,629 97,621 78,192 
Total SBC expense$212,695 $171,424 $126,918 
Schedule of Restricted Stock Activity
The following table shows the activity and weighted-average grant date fair value for RSUs during the fiscal year ended June 30, 2024:
Shares
(In thousands) (1)
Weighted-Average
Grant Date
Fair Value
Outstanding RSUs as of June 30, 2023(2)
1,715 $312.40 
Granted(2)
424 $584.49 
Vested and released(633)$229.02 
Forfeited(39)$366.93 
Outstanding RSUs as of June 30, 2024(2)
1,467 $424.66 
 __________________ 
(1)Share numbers reflect actual shares subject to awarded RSUs. Under the terms of the 2004 Plan for grants prior to November 1, 2023 or the terms of the 2023 Plan for grants on or after November 1, 2023, the number of shares subject to each award reflected in this number is multiplied by 2.0x to calculate the impact of the award on the share reserve under the respective plan.
(2)Includes performance-based RSUs. As of June 30, 2024, it had not yet been determined the extent to which (if at all) the performance-based criteria had been satisfied. Therefore, this line item includes all such RSUs, reported at the maximum possible number of shares (i.e., 0.1 million shares for the fiscal year ended June 30, 2024) that may ultimately be issuable if all applicable performance-based criteria are achieved at their maximum.
Schedule of Grant Date Fair Value, Weighted Average Grant Date Fair Value, and Tax Benefits for Restricted Stock Units
The following table shows the weighted-average grant date fair value per unit for the RSUs granted, aggregate grant date fair value of RSUs vested, and tax benefits realized by us in connection with vested and released RSUs for the indicated periods:
(In thousands, except for weighted-average grant date fair value)Year Ended June 30,
202420232022
Weighted-average grant date fair value per unit$584.49 $385.98 $353.27 
Grant date fair value of vested RSUs$144,888 $107,217 $74,794 
Tax benefits realized by us in connection with vested and released RSUs$47,315 $25,989 $23,634 
Schedule of Employee Stock Purchase Rights Valuation
The fair value of each purchase right under the ESPP was estimated on the date of grant using the Black-Scholes model and the straight-line attribution approach with the following weighted-average assumptions:
 Year Ended June 30,
 202420232022
Stock purchase plan:
Expected stock price volatility32.2 %42.7 %38.2 %
Risk-free interest rate5.3 %2.5 %0.1 %
Dividend yield1.1 %1.6 %1.2 %
Expected life (in years)0.500.500.50
Schedule of Tax Benefits Realized and Weighted-average fair value for the ESPP
The following table shows total cash received from employees for the issuance of shares under the ESPP, the number of shares purchased by employees through the ESPP, the tax benefits realized by us in connection with the disqualifying dispositions of shares purchased under the ESPP and the weighted-average fair value per share for the indicated periods:
(In thousands, except for weighted-average fair value per share)Year Ended June 30,
202420232022
Total cash received from employees for the issuance of shares under the ESPP$144,934 $124,731 $113,015 
Number of shares purchased by employees through the ESPP320 418 419 
Tax benefits realized by us in connection with the disqualifying dispositions of shares purchased under the ESPP$2,623 $1,916 $1,853 
Weighted-average fair value per share based on Black-Scholes model$125.04 $89.52 $94.35